Evaluation of Enzyme Inhibitors in Drug Discovery

A Guide for Medicinal Chemists and Pharmacologists

Nonfiction, Science & Nature, Science, Biological Sciences, Biochemistry
Cover of the book Evaluation of Enzyme Inhibitors in Drug Discovery by Robert A. Copeland, Wiley
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Robert A. Copeland ISBN: 9781118540282
Publisher: Wiley Publication: January 31, 2013
Imprint: Wiley-Interscience Language: English
Author: Robert A. Copeland
ISBN: 9781118540282
Publisher: Wiley
Publication: January 31, 2013
Imprint: Wiley-Interscience
Language: English

Offers essential guidance for discovering and optimizing novel drug therapies

Using detailed examples, Evaluation of Enzyme Inhibitors in Drug Discovery equips researchers with the tools needed to apply the science of enzymology and biochemistry to the discovery, optimization, and preclinical development of drugs that work by inhibiting specific enzyme targets. Readers will applaud this book for its clear and practical presentations, including its expert advice on best practices to follow and pitfalls to avoid.

This Second Edition brings the book thoroughly up to date with the latest research findings and practices. Updates explore additional forms of enzyme inhibition and special treatments for enzymes that act on macromolecular substrates. Readers will also find new discussions detailing the development and application of the concept of drug-target residence time.

Evaluation of Enzyme Inhibitors in Drug Discovery begins by explaining why enzymes are such important drug targets and then examines enzyme reaction mechanisms. The book covers:

  • Reversible modes of inhibitor interactions with enzymes
  • Assay considerations for compound library screening
  • Lead optimization and structure-activity relationships for reversible inhibitors
  • Slow binding and tight binding inhibitors
  • Drug-target residence time
  • Irreversible enzyme inactivators

The book ends with a new chapter exploring the application of quantitative biochemical principles to the pharmacologic evaluation of drug candidates during lead optimization and preclinical development.

The Second Edition of Evaluation of Enzyme Inhibitors in Drug Discovery continues to offer a treatment of enzymology applied to drug discovery that is quantitative and mathematically rigorous. At the same time, the clear and simple presentations demystify the complex science of enzymology, making the book accessible to many fields— from pharmacology to medicinal chemistry to biophysics to clinical medicine.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Offers essential guidance for discovering and optimizing novel drug therapies

Using detailed examples, Evaluation of Enzyme Inhibitors in Drug Discovery equips researchers with the tools needed to apply the science of enzymology and biochemistry to the discovery, optimization, and preclinical development of drugs that work by inhibiting specific enzyme targets. Readers will applaud this book for its clear and practical presentations, including its expert advice on best practices to follow and pitfalls to avoid.

This Second Edition brings the book thoroughly up to date with the latest research findings and practices. Updates explore additional forms of enzyme inhibition and special treatments for enzymes that act on macromolecular substrates. Readers will also find new discussions detailing the development and application of the concept of drug-target residence time.

Evaluation of Enzyme Inhibitors in Drug Discovery begins by explaining why enzymes are such important drug targets and then examines enzyme reaction mechanisms. The book covers:

The book ends with a new chapter exploring the application of quantitative biochemical principles to the pharmacologic evaluation of drug candidates during lead optimization and preclinical development.

The Second Edition of Evaluation of Enzyme Inhibitors in Drug Discovery continues to offer a treatment of enzymology applied to drug discovery that is quantitative and mathematically rigorous. At the same time, the clear and simple presentations demystify the complex science of enzymology, making the book accessible to many fields— from pharmacology to medicinal chemistry to biophysics to clinical medicine.

More books from Wiley

Cover of the book Transmission Lines in Digital and Analog Electronic Systems by Robert A. Copeland
Cover of the book Fair Value Measurements by Robert A. Copeland
Cover of the book Neonatology at a Glance by Robert A. Copeland
Cover of the book Building Beehives For Dummies by Robert A. Copeland
Cover of the book Out of the Box and onto Wall Street by Robert A. Copeland
Cover of the book Guidelines for Combustible Dust Hazard Analysis by Robert A. Copeland
Cover of the book Advanced Carbon Materials and Technology by Robert A. Copeland
Cover of the book A Concise History of the Haitian Revolution by Robert A. Copeland
Cover of the book Combustion Technology by Robert A. Copeland
Cover of the book Letters from Home by Robert A. Copeland
Cover of the book Shallow Foundations by Robert A. Copeland
Cover of the book The Mediterranean Diet by Robert A. Copeland
Cover of the book Weddings For Dummies, Mini Edition by Robert A. Copeland
Cover of the book Concurrent, Real-Time and Distributed Programming in Java by Robert A. Copeland
Cover of the book Sample Size Determination and Power by Robert A. Copeland
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy